Description Usage Format Source References
Survival in a randomised trial comparing two treatments for ovarian cancer
1 |
survival or censoring time
censoring status
in years
residual disease present (1=no,2=yes)
treatment group
ECOG performance status (1 is better, see reference)
Terry Therneau
Edmunson, J.H., Fleming, T.R., Decker, D.G., Malkasian, G.D., Jefferies, J.A., Webb, M.J., and Kvols, L.K., Different Chemotherapeutic Sensitivities and Host Factors Affecting Prognosis in Advanced Ovarian Carcinoma vs. Minimal Residual Disease. Cancer Treatment Reports, 63:241-47, 1979.
Add the following code to your website.
For more information on customizing the embed code, read Embedding Snippets.